(Q46548640)

23 December 2017

title

Clinical experience with linezolid for the treatment of central nervous system infections (English)

1 reference

23 December 2017

1 reference

T A Rupprecht

1

1 reference

23 December 2017

H-W Pfister

series ordinal

2

1 reference

23 December 2017

publication date

1 July 2005

1 reference

23 December 2017

European Journal of Neurology

published in

1 reference

23 December 2017

volume

12

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

536-542

1 reference

23 December 2017

Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Successful treatment of disseminated Mycobacterium chelonae infection with linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Oxazolidinone antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Hematologic effects of linezolid: summary of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Risk factors for neurosurgical site infections after craniotomy: a prospective multicenter study of 2944 patients. The French Study Group of Neurosurgical Infections, the SEHP, and the C-CLIN Paris-Nord. Service Epidémiologie Hygiène et Prévention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Multi-system Infection with Nocardia farcinica-therapy with linezolid and minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Linezolid: the first oxazolidinone antimicrobial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Clinical experience with linezolid for the treatment of nocardia infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus Endocarditis unresponsive to vancomycin therapy with linezolid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Linezolid resistance in a clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Linezolid for the treatment of central nervous system infections in neurosurgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Activities of linezolid against rapidly growing mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01001.X

10.1111/J.1468-1331.2005.01001.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

15958094

1 reference

23 December 2017